Back to Search
TIMOTHY BABINCHAK, MD
MD
Infectious Disease Physician
NPI: 1760811418Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD034147E(PA)
Research & Publications (17)
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
PMID 16080073·Clin Infect Dis·2005
3-trial
Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.
PMID 19073300·Diagn Microbiol Infect Dis·2009
8-other
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections - the European experience.
PMID 19036670·J Chemother·2008
3-trial
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
PMID 18684704·J Antimicrob Chemother·2008
3-trial
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
PMID 18684703·J Antimicrob Chemother·2008
3-trial
Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections.
PMID 17954694·Antimicrob Agents Chemother·2008
3-trial
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections.
PMID 17353238·Antimicrob Agents Chemother·2007
3-trial
Mortality and gram-negative rod bacteraemia in the intensive care unit.
PMID 16455161·J Hosp Infect·2006
8-other
Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community-associated isolates.
PMID 16251291·Antimicrob Agents Chemother·2005
3-trial
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
PMID 16236177·BMC Infect Dis·2005
3-trial
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.
PMID 16080072·Clin Infect Dis·2005
3-trial
Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
PMID 14746655·AIDS Patient Care STDS·2003
5-case
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
PMID 12746765·Clin Infect Dis·2003
3-trial
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.
PMID 12404155·J Infect Dis·2002
8-other
Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
PMID 11343220·J Infect Dis·2001
4-observational
Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.
PMID 10975963·Ann Intern Med·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 190 PEMBROOKE CIR, SUITE 101
PHOENIXVILLE, PA 19460 - Phone
- (610) 415-9486
Quick Facts
- NPI
- 1760811418
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile